Acquired thrombotic thrombocytopenic purpura · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Methylprednisolone monotherapy Variant #02 | — | R 2 802 | 23d | — | — | ~1 | ~R 2 802 indirect | — |
Vincristine monotherapy Variant #01 | — | — | 14d | — | — | ~2 | — | — |
Rituximab monotherapy Variant #09 Partial | — | — | 28d | ~20.3 mo | — | ~1 | — | 20 |
3 of 3 regimens shown